University of British Columbia

Study finds Medicaid coverage significantly reduces systolic blood pressure and HbA1c levels in low-income adults, with a 5 mm Hg reduction in blood pressure for those with minimal prior healthcare charges, highlighting the potential of Medicaid to improve cardiovascular health for specific subpopulations.

BMA hospital discharge increases drug overdose risk 10-fold in the following month, according to a study in the Canadian Medical Association Journal. Factors include improperly treated pain, cravings, stress, and untreated addiction. Researchers suggest developing protocols to prevent BMA discharge and postdeparture outreach to reduce overdose risk.

Vir Biotechnology appoints Jason O'Byrne as EVP and CFO, effective October 2, 2024, and Brent Sabatini as principal accounting officer, effective October 1, 2024.

Vir Biotechnology appoints Jason O’Byrne as CFO, effective October 2, 2024. O’Byrne brings over 20 years of finance and operations experience, previously serving as CFO at Caribou Biosciences and Senior VP of Finance at Audentes Therapeutics.

Vir Biotechnology appoints Jason O'Byrne as EVP and CFO, effective October 2, 2024. O'Byrne, with over 20 years of finance and operations experience, joins from Caribou Biosciences, where he led finance and operations. He previously served as SVP of Finance at Audentes Therapeutics and held roles at Genentech. O'Byrne holds a Bachelor of Applied Science in Mechanical Engineering and an MBA in Finance.